RPHMReneo PharmaceuticalsRPHM info
$1.50info7.91%24h
Global rank25216
Market cap$49.97M
Change 7d11.11%
YTD Performance-6.83%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Reneo Pharmaceuticals (RPHM) Stock Overview

    Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases. Its lead product candidate is REN001, a potent and selective agonist of the peroxisome proliferator-activated receptor delta that is in clinical development for genetic mitochondrial diseases comprising primary mitochondrial myopathies and long-chain fatty acid oxidation disorders. Reneo Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in Irvine, California.

    RPHM Stock Information

    Symbol
    RPHM
    Address
    18575 Jamboree RoadIrvine, CA 92612United States
    Founded
    -
    Trading hours
    -
    Website
    https://reneopharma.com
    Country
    πŸ‡ΊπŸ‡Έ United States
    Phone Number
    858 283 0280

    Reneo Pharmaceuticals (RPHM) Price Chart

    -
    Value:-

    Reneo Pharmaceuticals Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $1.50
    N/A
    Market Cap
    $49.97M
    N/A
    Shares Outstanding
    33.31M
    N/A
    Employees
    55.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org